Navigation Links
Copper surfaces reduce the rate of health care-acquired infections in the ICU
Date:4/9/2013

CHICAGO (April 9, 2013) Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half, according to a new study published in the May issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, in a special topic issue focused on the role of the environment in infection prevention.

In the United States, HAIs result in 100,000 deaths annually and add an estimated $45 billion to healthcare costs. HAIs often contaminate items within hospital rooms, allowing bacteria to transfer from patient to patient. Common microbes include methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). While several strategies have been developed to decrease HAIs, few have been clinically proven to reduce the spread of these infections. The researchers tested the capability of copper surfaces to reduce environmental contamination of these germs and thereby decrease HAIs in patients. Copper surfaces have an inherent ability to continuously kill environmental microbes on these surfaces.

The study was performed from July 12, 2010 to June 14, 2011 at three medical centers including the Medical University of South Carolina, the Memorial Sloan-Kettering Cancer Center, and the Ralph H. Johnson Veterans Affairs Medical Center. Patients who were admitted to the ICU of these hospitals were randomly assigned to receive care in a traditional patient room or in a room where items such as bed rails, tables, IV poles, and nurse's call buttons were made solely from copper-based metals. Both traditional patient rooms and rooms with copper surfaces at each institution were cleaned using the same practices.

The proportion of patients who developed HAI and/or colonization with MRSA or VRE was significantly lower among patients in rooms with copper surfaces (7.1%) compared with patients in traditional rooms (12.3%). The proportion of patients developing HAI was significantly lower among those assigned to copper rooms (3.4%) compared with those in traditional rooms (8.1%).

"Patients who suffer HAIs often stay in the hospital longer, incur greater costs, and unfortunately suffer a greater likelihood of dying while hospitalized," said Cassandra D. Salgado, MD, Associate Professor at the Medical University of South Carolina and lead author of the study. "Our study found that placement of items with copper surfaces into ICU rooms as an additional measure to routine infection control practices could reduce the risk of HAI as well as colonization with multidrug resistant microbes."

Previous attempts to reduce HAIs have required healthcare worker engagement or use of systems such as ultraviolet light, which may be limited because of regrowth of organisms after the intervention. In contrast, copper alloy surfaces offer a passive way to reduce burden, without staff intervention or involvement with outside providers.


'/>"/>

Contact: Tamara Moore
tmoore@gymr.com
202-745-5114
Society for Healthcare Epidemiology of America
Source:Eurekalert

Related medicine news :

1. Be Present Welcomes Wanderlust Festival to Copper Mountain, Colorado
2. UCLA study to determine if copper surfaces can reduce hospital-acquired infections
3. New Rocky Mountain Architectural Hardware Series Combines Artisan-quality Style and Beauty with CuVerro® Antimicrobial Copper
4. Copper Vista Dental Care LLC in Arizona Announces the Opening of its Globe Dental Office
5. Copper depletion therapy keeps high-risk triple-negative breast cancer at bay
6. Fungus uses copper detoxification as crafty defense mechanism
7. PotLocator Strikes Gold In Advertising Outreach to Copper State
8. Huntingtons Disease Linked to Reduced Cancer Risk in Study
9. BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport
10. Decision guide reduced uncertainty over breast cancer prevention, study finds
11. Scoliosis Treatment Might Reduce Need for Surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... VA (PRWEB) , ... June 23, 2017 , ... ... of what is needed and will ultimately do significant harm to people with ... to everyone. , "While it leaves in place the Affordable Care Act ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and ... of visual loss in these patients. , But how often do ophthalmologists and optometrists ... to patients at risk of or with early symptoms of AMD? A study ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique ... a proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does ... patients can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and South Asia ... 21 leaders from government, business and civil society in 11 countries across the Middle ... fall, engaging in a transformative exchange of knowledge and ideas with the leading minds ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: